Background: To improve the prediction of outcomes in patients who will undergo radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC), we examined the preoperative prognostic factors and established a risk classification model. Methods: A total of 148 patients who underwent RNU without history of neo-adjuvant chemotherapy between 1999 and 2016 in Hiroshima University Hospital were retrospectively reviewed. Associations between preoperative/clinicopathological factors and outcomes including cancer-specific survival (CSS) and recurrence-free survival (RFS) were assessed. We specifically looked at neutrophillymphocyte ratio (NLR) due to growing evidence on its predictive role in cancer prognosis prediction. Results: Preoperative elevated neutrophil-lymphocyte ratio (pre-op NLR, ≥3.0) and hydronephrosis (≥grade 2) were associated with advanced pathological stage; and were identified as independent predictive factors of shorter CSS and RFS in univariate and multivariate analysis. We classified the patients in three groups using preoperative factors and found that the 5-year CSS was 94.5, 75.9 and 44.7% and the 5-year RFS was 74.3, 57.6 and 28.7% in the low-risk group (neither pre-op NLR nor hydronephrosis), intermediate-risk group (either pre-op NLR or hydronephrosis) and high-risk group (pre-op NLR and hydronephrosis), respectively. High-risk group had significantly worse CSS (P = 0.0172) and RFS (P = 0.0014) than intermediate-risk group and low-risk group (CSS (P < 0.0001) and RFS (P < 0.0001)). Conclusions: Elevated pre-op NLR and hydronephrosis were identified as independent prognostic factors in patients with UTUC. These simple preoperative factors can stratify three prognostic groups and may help urologists in clinical decision-making before RNU.
Introduction
Upper tract urothelial carcinoma (UTUC), arising from renal pelvis and ureters, is responsible for 5-10% of all urothelial carcinoma in urinary system (1) . Radical nephroureterectomy (RNU) with excision of bladder cuff is standard treatment for UTUC (2) . Despite negative surgical margins, local recurrence and distant metastasis are not uncommon and prognosis of patients with recurrent or metastatic disease has still been unsatisfactory (2, 3) . Most of the recurrence does usually happen within the first few years after RNU (4). The 5-year cancer-specific survival (CSS) is less than 50% for pT2/pT3 tumors and less than 10% for pT4 tumors (2) . The pathologic characteristics of RNU specimens including stage, grade, lymph node status, concomitant carcinoma in situ (CIS) and lymphovascular invasion (LVI) has been found as significant prognostic variables for CSS and recurrence-free survival (RFS) in different studies (5) (6) (7) . Although these pathological parameters are strong predictors of clinical outcome, this information is not available before surgery. When survival outcome can be predicted using clinical parameters available before the surgery, they might be utilized to improve perioperative planning, including consideration of lymphadenectomy and/or neo-adjuvant chemotherapy.
So far, several studies have reported the age (8) , gender (9) , preoperative symptom (10) , location (11) , clinical stage (11) and hydronephrosis (12) (13) (14) (15) as the preoperative clinical predictors of survival in UTUC. In the recent couple of years, the involvement of systemic inflammatory response in cancer development and progression has been investigated into more detail. The neutrophil-lymphocyte ratio (NLR) has been suggested as a simple index of systemic inflammation in many cancers, and growing body of evidence has demonstrated that a high preoperative NLR (pre-op NLR) is a significant independent marker of predicting poor outcomes (16) (17) (18) .
In this study, we aimed to evaluate preoperative prognostic factor in patients with UTUC and to establish prognostic stratification model before the surgery.
Materials and methods
This retrospective study was approved by the Ethics Committee at the Hiroshima University (authorization numbers:E-589). The medical records of patients who underwent RNU for unilateral UTUC at Hiroshima University Hospital between April 1999 and April 2016 were retrospectively reviewed. RNU was performed using either an open or laparoscopic approach with open distal ureteric excision in all cases. Patients with neo-adjuvant chemotherapy, active infection such as pyelonephritis treated with antibiotics, the presence of collagen vascular disease, hematopoietic disease, chronic inflammatory disease, prior steroid therapy or hemodialysis were excluded from this study. In addition, patients who did not have preoperative blood work or available neutrophil and lymphocyte counts were also excluded. Using these criteria, we excluded 41 patients from this study. The remaining 148 patients were included in this study.
We obtained the relevant clinicopathological data from medical records, such as age, gender, tumor locations, tumor grades, pathological TN stage, LVI, concomitant CIS, resected margin status, NLR, hypoalbuminemia, the presence or absence of hydronephrosis, concomitant bladder tumors and adjuvant chemotherapy. We defined tumor location as the location of main tumor, when there were multiple tumors. According to the 2002 American Joint Committee on Cancer/Union for International Cancer Control (AJCC/UICC) TNM classification (19) , pathology specimens were examined and re-reviewed for staging. To evaluate tumor grading, we used WHO International Society of Urological Pathology Consensus classification (20) . We looked at preoperative blood work and included relevant data only if it was done within a month before surgery. We did not include white blood cells, neutrophils, lymphocytes and C-reactive protein (CRP) as separate variables as they are other markers of inflammation like NLR and may function since confounding factors. NLR was calculated dividing absolute neutrophil count by absolute lymphocyte count and elevated pre-op NLR cutoff considered when it was above 3.0, as per previous studies (21) (22) (23) . In our institute, we perform unenhanced CT and contrast-enhanced CT images for the patients with normal renal function, and radiologists will review the images for clinical staging. All CT scans within 2 months prior to RNU were included for evaluation in this study. Ipsilateral hydronephrosis was graded as 0-4 according to Cho et al. classification, and we re-reviewed all the images and considered hydronephrosis when it was higher than grade 2 according to this classification (24) .
End-points of this study were CSS and RFS. Disease recurrence was defined as any documented first relapse in lymph nodes or evidence of distant metastases, whereas bladder cancer recurrence or contralateral UTUC was not considered as recurrence. Our follow-up protocol consisted of complete blood counts, serum chemistry tests, urine analysis, chest abo-pelvis CT scan with or without contrast every 3-6 months for at least 5 years based on different physician preferences and the last follow-up date was 30 September 2016.
Statistical analysis
All continuous variables are shown as median values and interquartile ranges (IQRs). Pearson's chi-square test and Fisher exact test were used to compare the distribution of categorical variables. Differences in variables with continuous distribution across dichotomous categories were tested using Mann-Whitney U test. Associations between clinicopathological parameters and prognosis were assessed in univariate and multivariate models using Cox proportional hazard regression models. We used Kaplan-Meier method to evaluate the survival outcomes and Log-rank test to assess the difference. A value of P < 0.05 was considered to be statistically significant for each comparison.
Results

Patients' characteristics in our UTUC cohort
The mean age of all included patients was 71 (IQR 64-78) years (Table 1) , and the follow-up duration was 35.5 months (IQR 12-66). Males accounted for 75.7% (112 patients) of the cohort. The median pre-op NLR was 2.21 (IQR 1.64-3.00), and 38 (25.7%) patients had an elevated pre-op NLR. Sixty-eight patients (45.9%) had hydronephrosis. In terms of pathological findings, 60 (39.5%) patients had low-grade disease (G1/2), and 92 (60.5%) patients had high-grade disease (G3). The pathological T stage was recorded as Ta/1 in 70 and T2 in 12 patients, which accounted for 55.4% of the cohort, and T3 in 61 and T4 in five patients, which accounted for 44.6% of the cohort. Resected margin was positive in 12 (8.1%) patients. Lymph node dissection (LND) was performed in 37 cases and 8 positive lymph node involvement cases were found. Adjuvant chemotherapy was used in 25 (16.9%) patients. During the follow-up period, disease recurrence was observed in 50 (33.8%) patients, and 25 (16.9%) of them died of the disease. The 3-year CSS and RFS were 84.6 and 68.0%.
Predictive factors for CSS and RFS
First, we analyzed the role of most reported predictive clinicopathological factors in CSS and RFS (Table 2 ). Univariate analysis revealed that age, gender, tumor location, resected margin status, concomitant CIS, pN stage, hypoalbuminemia, concomitant bladder tumor and adjuvant chemotherapy were not associated with poor CSS. However, an advanced pT stage (≥T3), histological Grade 3, positive LVI, elevated pre-op NLR and hydronephrosis were associated with poor CSS. Multivariate analysis revealed that elevated pre-op NLR (P = 0.009; hazard ratio (HR) 3.25) and hydronephrosis (P = 0.017; HR 2.97) were independent clinical risk factor for predicting poor CSS as well as pathological T stage, tumor grade and positive LVI.
Univariate and multivariate analyses were also performed to determine indicators for predicting RFS (Table 3) . Univariate analysis revealed that the advanced pT stage (≥T3), histological Grade 3, positive LVI, lymph node stage, elevated pre-op NLR and hydronephrosis were associated with RFS. Multivariate analysis was performed with these factors without including lymph node stage given that only a small number of cases (37, 25.0%) had LND during the surgery. Multivariate analysis revealed that elevated pre-op NLR (P = 0.024; HR 2.13) and hydronephrosis (P = 0.008; HR 2.25) were independent clinical risk factor for RFS, in addition to pathological indicator of positive LVI.
Pre-op NLR and hydronephrosis are significant predictors for CSS and RFS
To address the clinical significance of elevated pre-op NLR and the grade of hydronephrosis before RNU, we looked at RFS and CSS and performed a Kaplan-Meier analysis. Patients with elevated preop NLR had significantly worse CSS (P < 0.0001) (Fig. 1A ) and RFS (P < 0.0001) (Fig. 1B) . Furthermore, the patients with hydronephrosis also had significantly worse CSS (P = 0.0001) (Fig. 1C ) and RFS (P < 0.0001) (Fig. 1D) . These results revealed that both elevated pre-op NLR and hydronephrosis are significant predictors for RFS and CSS.
Both pre-op NLR and hydronephrosis significantly correlated with an advanced stage
In the next step, we evaluated the association between pre-op NLR with pathological factors and hydronephrosis, to address the significance of pre-op NLR in the oncological outcomes. Elevated pre-op NLR was associated with higher pN stage and hydronephrosis, while it was not associated with pT stage, tumor grade, LVI, concomitant CIS and concomitant bladder tumors (Table 4) .
We also evaluated the association between hydronephrosis and pathological factors. The association between hydronephrosis and pathological factors is shown in Table 5 . Our analysis revealed that hydronephrosis associated with higher histological grade, higher pT stage and tumor location (Table 5 ). These results suggest that both elevated pre-op NLR and hydronephrosis could accurately predict advanced pathological stage and grade.
Risk classification by using pre-op NLR and hydronephrosis
Finally, we tried to make a preoperative prognostic risk classification model using pre-op NLR and hydronephrosis in patients with UTUC. We considered patients with both elevated pre-op NLR and hydronephrosis as the high-risk group, those with either elevated pre-op NLR or hydronephrosis as the intermediate-risk group, and those with neither elevated pre-op NLR nor hydronephrosis as the low-risk group. The low-risk, intermediate-risk and high-risk group consisted 43.9% (n = 65), 40.5% (n = 60) and 15.5% (n = 23) of all patients, respectively. The baseline characteristics of each risk group (Table 6) showed that higher risk groups included patients with higher histological grade and advanced stage.
Kaplan-Meier curves revealed that high-risk group had significantly worse CSS (P < 0.0001) and RFS (P < 0.0001) than the lowrisk group. The high-risk group had also significantly worse CSS (P = 0.0172) and RFS (P = 0.0014) than the intermediate-risk group (Fig. 2) . The 5-year CSS was 94.5, 75.9 and 44.7% and the 5-year RFS was 74.3, 57.6 and 28.7% in the low-risk group, intermediaterisk group and high-risk group, respectively.
Because ureteric cancer has been associated with higher frequency of hydronephrosis than renal pelvis cancer, we evaluated the IQR, interquartile range; CIS, carcinoma in situ utility of the risk classification in renal pelvis cancer and ureter cancer separately. Kaplan-Meier curves revealed that in both renal pelvis cancer and ureter cancer, high-risk group had significantly worse CSS (P < 0.0001 and P = 0.0030) and RFS (P < 0.0001 and 0.0004) than the low-risk group in both renal pelvis and ureteric cancers. The high-risk group had also significantly worse CSS (P = 0.0134 and 0.0205) and RFS (P = 0.0004 and 0.0064) than the intermediate-risk group in any locations (Fig. 3 ).
Discussion
In this study, we have demonstrated that elevated pre-op NLR and hydronephrosis were independent prognostic factors in UTUC and could be used as prognostic predictors before the surgery, which are same as the previous studies. We also demonstrated that stratify three prognostic groups using pre-op NLR and hydronephrosis were accurately predict prognosis. To our knowledge, there are no previous studies classifying prognostic groups using pre-op NLR and hydronephrosis.
The outcomes of patients with UTUC are heterogeneous; therefore, there is no risk stratification of UTUC before RNU. In fact, radical cystectomy is recommended in T2-T4aN0M0, and nonmuscle invasive bladder cancer (Tis/a/1) is managed by transurethral resection of bladder cancer (TURBT) and followed by intravesical chemotherapy and immunotherapy according to risk classification as an European association of Urology (EAU) risk group stratification. However, gold standard of treatment for localized UTUCs is radical nephroureterectomy regardless of staging. Simple and practical risk stratification of UTUC before RNU for treatment planning is required, because there is no strategy to define what kind of patients should have neo-adjuvant chemotherapy, more extensive LND and closer postoperative follow-up. NLR, neutrophil-lymphocyte ratio; CIS, carcinoma in situ.
a Lymphovascular Invasion and concomitant CIS included three unknown cases. Growing body of evidence has suggested that elevated pre-op NLR is associated with poor oncological outcomes for several types of cancers, including urothelial carcinoma (16) (17) (18) (21) (22) (23) , and our findings are along with the other studies ( Fig. 1A and B) . NLR represents two opposing systematic inflammatory responses that exist together in cancer patients. The first one, neutrophils, plays its role through their enzymatic activation, promote remodeling of the extracellular matrix, release of basic fibroblast growth factors, migration of endothelial cells and dissociation of tumor cells (16, 25) . The other one, lymphocytes, are the main components of antitumor immunity by inducing cytotoxicity, reducing tumor growth and promoting apoptosis of tumor cells (26) . In our study, pre-op NLR was associated with the higher pN stage, which suggests that systematic inflammatory response pathway may play a significant role in oncological outcome in patients, which also mentioned in Bugada et al.'s study (27) .
Preoperative hydronephrosis was found to be associated with higher tumor grade, pT stage (Table 5 ), RFS and CSS (Fig. 1C and  D) in our study. This is in line with the previous studies (12, 13) . Although we previously reported that contrast-enhanced CT-based grading could predict higher T stage (≥T3) in ureteral cancers (28) , estimation of the pathologic invasion depth in UTUC, which is actually the differentiation between invasive (≥T2) and noninvasive (≤T1) UTUC, is not accurate (29) . Simple image diagnosis is part of routine preoperative investigation and can easily detect the presence of hydronephrosis. The presence of hydronephrosis may imply extension of tumor to the out layers of urothelium, which may be an indicator of cancer cells spreading to the reginal nodes or distant organs. Given that the high-pressure hydronephrotic lumen is thinner than normal lumen, the likelihood of spreading beyond the urothelial layers can be potentially higher. The increased intraluminal pressure may also cause counterflow in lymphatics and vasculature, leading to increased cancer seeding rate (30) . Although we initially thought that it is more likely to see hydronephrosis in ureteric tumors than renal pelvis ones and this may affect the predictive value of hydronephrosis, separate analysis in these two subgroups ruled out this assumption. Therefore, we think that hydronephrosis could be considered as a useful independent preoperative predictor of prognosis for both renal pelvic and ureteric urothelial cancers.
Since we figured out that both pre-op NLR as a marker of systematic inflammation and hydronephrosis as an indicator of higher pressure in urinary tract are strong independent prognostic predictive factors of ourcomes, we then tried to establish a predictive model using these two factors. We believe that our classification using preop NLR and hydronephrosis will contribute to improve the outcome of patients with UTUC in daily practice due to the fact that more extensive LND and neo-adjuvant chemotherapy may be considered in surgical planning and this may improve the outcome of advanced UTUCs (31) (32) (33) . It goes without saying that this simple classification does not add any further costs or investigations, since all of the patients will get blood work and CT scan before the surgery, however, further clinical study is required to validate our classification.
Some limitations to our study are evident. First, these results were analyzed retrospectively, and unknown bias may exist when it comes to the interpretation of findings. In addition, the relatively small number of patients included in this study may reduce its validity. Second, although we excluded the patients with other possible inflammatory responses due to other comorbidities, it is still possible that we may have missed other confounding disease with similar effects on the blood counts. Third, potential inter-observer reliability issues may have existed during radiology readings when it comes to the degree of hydronephrosis, or at the time of pathologic examinations with different uro-pathologists. Further validation and feasibility studies are required before the results of this study can be generalized and used in the routine practice.
In conclusion, elevated pre-op NLR and hydronephrosis were identified as independent prognostic factors in patients treated with RNU, and our simple classification using these two factors may be a useful preoperative predictive model in patients with UTUC.
